$SG

Sweetgreen Stumbles Again. Are the Turnaround Chances Gone?

Sweetgreen (NYSE: SG) reported another weak quarter after hours, with shares down double digits before partially recovering. Same-store sales decline narrowed to 6.2% in Q2 from 12.8% in Q1, but a cyclospora outbreak hurt July comps, cutting full-year guidance to same-store sales down 7%-8% and adjusted EBITDA loss of $23M-$27M. Management cited improving throughput and wrap adoption.

Original reporting
Published Aug 8, 2026, 12:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 12:13 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Sweetgreen Stumbles Again. Are the Turnaround Chances Gone? — source image
Decision brief

The 30-second read

$SGBearishMed
01

Why it matters

The cyclospora outbreak created a demand shock that forced management to materially widen the expected decline in same-store sales and move adjusted EBITDA to a loss, while also stating recovery timing is uncertain.

02

Market read

Traders should focus on the magnitude of the guidance reset and the stated uncertainty around recovery timing, since it directly affects forward estimates and risk premium for the turnaround.

03

What to watch

The article notes iceberg lettuce is not used and products were not directly affected, implying the demand hit could mean-revert faster than the market assumes once consumer fears subside.

Relevance 8/10Novelty 6/10Timing: after-hours earnings report, with stock down double digits Friday morning

Background

Sweetgreen is in an ongoing turnaround, with prior declines in same-store sales and a strategy shift toward wraps, pricing changes, and throughput improvements.

Company-level read

Ticker impact

$SGBearishMedium confidence
Context

Sweetgreen reported another disappointing earnings result and cut full-year same-store sales guidance to down 7%-8% after a cyclospora outbreak hit comps.

Expected impact

Bearish near term, with potential for stabilization only if early-July-style positive comps return after the outbreak fades.

Evidence & confidence

The article cites a concrete guidance cut (comps and adjusted EBITDA) tied to the cyclospora-driven demand shock, which typically pressures valuation until visibility improves.

Market effects

Highlights fast-casual demand sensitivity to food-safety scares and the importance of throughput and value perception in sustaining comps.

No specific regional market impact beyond mention of New York and Seattle wrap adoption.

Limited, as the shock appears localized to consumer behavior around the outbreak rather than a global supply disruption.

Counterpoint

Operational metrics (throughput improvements, wrap adoption, pricing changes) suggest the business model is adjusting, so the guidance cut may be temporary if demand normalizes.

Key entities

  • Sweetgreen

    Fast-casual restaurant chain whose earnings and full-year guidance were cut due to cyclospora-related consumer fear.

  • cyclospora outbreak

    Food-safety outbreak that management links to a July comparable sales deterioration and guidance reset.

Related articles

$SGHighAI 9/10

Why Sweetgreen Stock Tumbled Today

Sweetgreen (SG) shares fell after the company missed Q2 estimates and cut full-year guidance, citing a cyclospora outbreak impact on demand even though it said it was not directly affected. Same-store sales fell 6.2% and revenue rose 3.8% to $192.7M. Restaurant margin and adjusted EBITDA deteriorated, and GAAP loss per share widened to $0.22.

$SGMedAI 8/10

Sweetgreen Q2 2026 Loss Deepens:

Sweetgreen (NYSE:SG) reported Q2 2026 results that missed consensus. Diluted loss was $0.22 per share, 83.3% worse than the $0.12 loss estimate. Revenue was $192.7M, slightly below the $194.9M forecast. Net loss was $26.3M, same-store sales fell 6.2%, and shares dropped 3.8% to $5.87.

$SGHighAI 9/10

Sweetgreen Stock Slides Friday: What's Driving the Action? - Sweetgreen (NYSE:SG)

Sweetgreen (NYSE:SG) shares fell about 9.7% in premarket after Q2 results missed expectations. The company reported a net loss of 22 cents per share versus a 14 cent loss estimate, with revenue of $192.66 million below $194.90 million. Same-store sales declined 6.2%, and restaurant profit margin fell to 13.1%. Sweetgreen cut its 2026 outlook, citing weaker demand after a cyclosporiasis outbreak; TD Cowen lowered its price target to $5 from $8.

$SGHighAI 9/10

Sweetgreen revised its 2026 same-store sales outlook to a 7% to 8% decline, down from a prior 2% to 4% forecast,…

Sweetgreen revised its 2026 same-store sales outlook to a 7% to 8% decline, down from a prior 2% to 4% forecast, citing weaker demand for fresh prepared foods after a multistate cyclosporiasis outbreak. The company said cyclospora headlines disrupted momentum from mid-July, with July comparable sales down about 600 bps. Sweetgreen reported Q2 same-store sales down 6.2% and guided FY adjusted EBITDA loss of $27m to $23m.